Thirdly, this isolate was more resistant to spectinomycin than what is generally experienced with N. gonorrhoeae cultures. Our laboratory tests approximately 3,500 N. gonorrhoeae cultures annually, and the MIC of spectinomycin is higher for N. meningitidis than for N. gonorrhoeae (3) .
It is of particular interest that a second similar microorganism has been isolated in Canada from a female genital specimen. It displays the same biochemical and serological characteristics as those previously described (2) , except that it reduces nitrite (0.001%) and is GonoType 1 (J. R. Green, M. J. S. Dixon, and F. E. Ashton, unpublished observations). (1, 4) or biotype differences between isolates from veterinary and human sources (1, 3, 6) .
I am puzzled as to why a study performed at this laboratory (2) , evaluating the API 20E system, was not included in the quoted literature on packaged identification systems. This study was performed independently of Swanson and Collins (6). It found a lower level of identification than in similar studies with isolates derived from humans and suggested this could be due to different biotypes and an incomplete data base. These studies of Blackall (2) Author's Reply Authors are instructed to cite "all relevant published work" (Instructions to Authors, J. Clin. Microbiol. 25:iv, 1987) and to "Choose references carefully to provide the most salient background rather than an exhaustive review of the topic" (Instructions to Authors, J. Clin. Microbiol. 25:iii, 1987) . The objective of our study (4) was to evaluate the Quantum II microbiology system with bacteria of animal origin rather than rely on evaluations performed with isolates from humans (5-7, 10). Therefore, in reviewing the literature, I chose to cite and compare in the Discussion all reports that I could find evaluating the Quantum II microbiology system. However, I did not intend to review all the literature or to represent the paper as an exhaustive review of the literature that evaluates packaged identification systems with bacteria of animal origin. A few representative reports were selected as a relevant sample to illustrate to readers that there is a need to perform these evaluations.
I can assure Dr. Blackall that I did not choose to slight his work (1) . I am sorry that I omitted citing this report which he considered relevant to our paper. VOL. 26, 1988 on August 14, 2017 by guest http://jcm.asm.org/ Downloaded from I am certain that other authors must be perplexed when faced with the task of choosing which papers to cite. The tremendous information explosion has made it very difficult to accurately compile an exhaustive review of the literature and even more difficult to evaluate and choose "salient background" references. Dr. Blackall's letter illustrates this point. He claims that his paper (1) and a report (9) I chose to cite "represent . . . the first, and so far only, evaluations of the API 20E system with ... Enterobacteriaceae from animals." In a brief scan of the literature, I have found three additional reports (3, 8; C. S. McCain and K. Srisuparbh, Am. Assoc. Vet. Lab. Diagnosticians 20th Annual Proc., p. [351] [352] [353] [354] [355] [356] 1977 ) describing evaluations of the API 20E system with clinical isolates of Enterobacteriaceae from animals (I do not consider this to be an exhaustive review, but only sufficient to illustrate my point). Even in his own paper (1), Dr. Blackall cited a study that used isolates from poultry and meat products (2) , which are generally considered to be of animal origin. Indirectly, this study probably used isolates originating from animals and by some persons might be considered an omission from Dr. Blackall's letter.
I am grateful for this opportunity to reply and hope that this discussion can somehow help authors and editors to seek solutions to the perplexing problem of literature citation.
